Studies have demonstrated that the correlation of TNF-α and IL-1 with critical COVID-19 cases [82,84,89,90], and the immunomodulation of TNF-α and IL-1 by MSCs observed in this study could be a potential treatment for reducing COVID-19 mortality. This evidence concerns the gene TNF and COVID-19.